project id: TCGA-SKCM; case submitter id: TCGA-EE-A2ML; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 9.3; age at index: 35; days to birth: -13140; days to death: 6590; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1959; age at diagnosis: 13140; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T3a; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 6176.0; icd 10 code: C77.3; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph nodes of axilla or arm; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1994; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 6083; days to sample procurement: 0; portion submitter id: TCGA-EE-A2ML-06A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;